rs2665691
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_020346.3(SLC17A6):c.458+6345A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.656 in 151,986 control chromosomes in the GnomAD database, including 33,323 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.66 ( 33323 hom., cov: 31)
Consequence
SLC17A6
NM_020346.3 intron
NM_020346.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.493
Publications
5 publications found
Genes affected
SLC17A6 (HGNC:16703): (solute carrier family 17 member 6) Predicted to enable L-glutamate transmembrane transporter activity and neurotransmitter transmembrane transporter activity. Involved in neurotransmitter loading into synaptic vesicle. Predicted to be located in synaptic vesicle. Predicted to be active in excitatory synapse. Predicted to be integral component of synaptic vesicle membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.699 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.657 AC: 99707AN: 151868Hom.: 33303 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
99707
AN:
151868
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.656 AC: 99770AN: 151986Hom.: 33323 Cov.: 31 AF XY: 0.650 AC XY: 48246AN XY: 74274 show subpopulations
GnomAD4 genome
AF:
AC:
99770
AN:
151986
Hom.:
Cov.:
31
AF XY:
AC XY:
48246
AN XY:
74274
show subpopulations
African (AFR)
AF:
AC:
27659
AN:
41466
American (AMR)
AF:
AC:
8000
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
2553
AN:
3468
East Asian (EAS)
AF:
AC:
1833
AN:
5156
South Asian (SAS)
AF:
AC:
2885
AN:
4814
European-Finnish (FIN)
AF:
AC:
6875
AN:
10572
Middle Eastern (MID)
AF:
AC:
220
AN:
294
European-Non Finnish (NFE)
AF:
AC:
47825
AN:
67944
Other (OTH)
AF:
AC:
1410
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1684
3368
5053
6737
8421
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
798
1596
2394
3192
3990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1750
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.